$-0.19 EPS Expected for AxoGen, Inc. (AXGN); Nuveen Tax-advantaged Dividend Growth Fund (JTD)’s Sentiment Is 0.73

Analysts expect AxoGen, Inc. (NASDAQ:AXGN) to report $-0.19 EPS on August, 7.They anticipate $0.05 EPS change or 35.71% from last quarter’s $-0.14 EPS. After having $-0.21 EPS previously, AxoGen, Inc.’s analysts see -9.52% EPS growth. The stock decreased 0.10% or $0.02 during the last trading session, reaching $19.87. About 236,368 shares traded. AxoGen, Inc. (NASDAQ:AXGN) has declined 48.16% since July 9, 2018 and is downtrending. It has underperformed by 52.59% the S&P500. Some Historical AXGN News: 21/05/2018 - AxoGen Inc. Announces Appointment of Karen Zaderej as Chmn of the Bd; 15/05/2018 - Arrowmark Partners Buys New 3.4% Position in AxoGen; 14/05/2018 - AxoGen Expects Net Proceeds of $132.5 Million; 21/05/2018 - AXOGEN INC - ELECTED KAREN ZADEREJ AS CHAIRMAN OF BOARD IN ADDITION TO CURRENT ROLE AS PRESIDENT AND CEO; 12/04/2018 - AxoGen, Inc. Announces 2018 Annual Shareholders’ Meeting; 21/05/2018 - AxoGen, Inc. Announces Appointment of Karen Zaderej as Chairman of the Board; 30/04/2018 - AxoGen 1Q Adj Loss/Shr 11c; 21/05/2018 - AXOGEN, NAMES KAREN ZADEREJ AS CHAIRMAN OF BOARD; 10/04/2018 Factors of Influence in 2018, Key Indicators and Opportunity within Randgold Resources, GasLog Partners LP, Mountain Province D; 30/04/2018 - AxoGen 1Q Rev $17.3M

Nuveen Tax-advantaged Dividend Growth Fund (JTD) investors sentiment increased to 0.73 in Q1 2019. It’s up 0.06, from 0.67 in 2018Q4. The ratio has increased, as 8 funds opened new and increased equity positions, while 11 reduced and sold their holdings in Nuveen Tax-advantaged Dividend Growth Fund. The funds in our database now have: 1.49 million shares, down from 1.58 million shares in 2018Q4. Also, the number of funds holding Nuveen Tax-advantaged Dividend Growth Fund in top ten equity positions was flat from 1 to 1 for the same number . Sold All: 2 Reduced: 9 Increased: 6 New Position: 2.

More notable recent AxoGen, Inc. (NASDAQ:AXGN) news were published by: Finance.Yahoo.com which released: “Have Insiders Been Selling AxoGen, Inc. (NASDAQ:AXGN) Shares This Year? - Yahoo Finance” on June 18, 2019, also Finance.Yahoo.com with their article: “Here’s What Hedge Funds Think About AxoGen, Inc. (AXGN) - Yahoo Finance” published on June 14, 2019, Seekingalpha.com published: “The Street Still Highly Skeptical On AxoGen’s Growth Story - Seeking Alpha” on June 21, 2019. More interesting news about AxoGen, Inc. (NASDAQ:AXGN) were released by: Finance.Yahoo.com and their article: “Here’s What Hedge Funds Think About Stoneridge, Inc. (SRI) - Yahoo Finance” published on June 19, 2019 as well as Globenewswire.com‘s news article titled: “Axogen, Inc. to Participate at Upcoming Investor Conferences - GlobeNewswire” with publication date: May 23, 2019.

AxoGen, Inc. provides surgical solutions for peripheral nerve injuries. The company has market cap of $779.01 million. The company's surgical nerve repair solutions include Avance Nerve Graft, an off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix coaptation aid for tensionless repair of severed nerves; and AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect injured peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments. It currently has negative earnings. The Company’s solutions also comprise Avive Soft Tissue Membrane, a minimally processed human umbilical cord membrane that is used as a resorbable soft tissue covering to separate tissues and modulate inflammation in the surgical bed.

Among 3 analysts covering AxoGen (NASDAQ:AXGN), 3 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. AxoGen had 6 analyst reports since February 27, 2019 according to SRatingsIntel. The stock of AxoGen, Inc. (NASDAQ:AXGN) earned “Buy” rating by BTIG Research on Monday, March 25. On Wednesday, February 27 the stock rating was maintained by Jefferies with “Buy”. The firm has “Buy” rating by Cantor Fitzgerald given on Wednesday, February 27.

Nuveen Tax-Advantaged Dividend Growth Fund is a closed-ended equity mutual fund launched by Nuveen Investments, Inc. The company has market cap of $243.63 million. The fund is co-managed by Nuveen Fund Advisors, LLC, Santa Barbara Asset Management, Inc., Nuveen Asset Management, LLC, and NWQ Investment Management Company, LLC. It currently has negative earnings. It invests in the public equity markets of the United States.

Shaker Financial Services Llc holds 2.28% of its portfolio in Nuveen Tax-Advantaged Dividend Growth Fund for 280,734 shares. Rmb Capital Management Llc owns 127,927 shares or 0.05% of their US portfolio. Moreover, Bkd Wealth Advisors Llc has 0.04% invested in the company for 33,517 shares. The California-based Hollencrest Capital Management has invested 0.03% in the stock. Burt Wealth Advisors, a Maryland-based fund reported 1,200 shares.

More notable recent Nuveen Tax-Advantaged Dividend Growth Fund (NYSE:JTD) news were published by: Businesswire.com which released: “Nuveen Announces Portfolio Management Update - Business Wire” on June 10, 2019, also Businesswire.com with their article: “Nuveen Closed-End Funds Declare Distributions - Business Wire” published on June 03, 2019, Investorplace.com published: “3 CEFs to Buy for Safe Yields and Upside (USA, GAB, JTD) - Investorplace.com” on May 01, 2017. More interesting news about Nuveen Tax-Advantaged Dividend Growth Fund (NYSE:JTD) were released by: Seekingalpha.com and their article: “Several Tax Advantaged Funds That Pay Over 7%: Which Ones Should A Retiree Buy? - Seeking Alpha” published on July 16, 2016 as well as Seekingalpha.com‘s news article titled: “How Much Allocation To CEFs Is Too Much For An Income Investor? - Seeking Alpha” with publication date: November 09, 2015.

The stock decreased 0.18% or $0.03 during the last trading session, reaching $16.82. About 33,828 shares traded or 31.06% up from the average. Nuveen Tax-Advantaged Dividend Growth Fund (JTD) has declined 5.65% since July 9, 2018 and is downtrending. It has underperformed by 10.08% the S&P500.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.